10:01 AM EDT, 03/28/2024 (MT Newswires) -- Stephen Davis, Director, CEO, on March 27, 2024, sold 17,714 shares in Acadia Pharmaceuticals ( ACAD ) for $317,081. Following the Form 4 filing with the SEC, Davis has control over a total of 118,842 shares of the company, with 118,842 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1070494/000141588924009271/xslF345X03/form4-03272024_110307.xml

Price: 18.16, Change: -0.04, Percent Change: -0.22